By
Latest Stories
Don’t miss our hot and upcoming stories
Novartis and Generate:Biomedicines Announce Strategic AI-Driven Protein Therapeutics Partnership Worth Up to $1 Billion
Somerville, MA — Sept 24, 2024 Combining AI innovation with pharma expertise to accelerate drug…
Eli Lilly and Genetic Leap Forge $409M Strategic Collaboration to Advance AI-Powered RNA Drug Discovery
New York – Sept 24 2024 Eli Lilly and Company (NYSE: LLY) has entered into…
Rakovina Therapeutics and Variational AI Partner to Advance AI-Driven Cancer Drug Discovery
Vancouver, BC – September 17, 2024 Rakovina Therapeutics Inc. (TSX-V: RKV), a Canadian biopharmaceutical company…
Gilead Expands AI-Driven Drug Discovery Capabilities Through Strategic Collaboration with Genesis Therapeutics
BURLINGAME, California – Sept 10, 2024 Gilead Sciences, Inc. (Nasdaq: GILD) and Genesis Therapeutics have…